Evidence map›Paper›PMID 40940393›Full record

ArticleScientific reports2025

Age, muscle, and gender specific characterization of muscle degeneration in a mouse model of calpainopathy.

Nicolina Südkamp, Jacqueline Heinen-Weiler, Marlena Rohm, Michaela Zaik, Nassam Daya, Anne-Katrin Güttsches, Carsten Theiss, Andreas Roos, Tobias Ruck, Frank Jacobsen and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Nicolina SüdkampDepartment of Neurology, BG-University Hospital Bergmannsheil gGmbH, Ruhr University Bochum, Bochum, Germany. nicolina.suedkamp@rub.de.
Jacqueline Heinen-WeilerMedical Imaging Center (MIC), Electron Microscopy Medical Analysis - Core Facility (EMMACF), Faculty of Medicine, Ruhr University Bochum, 44780, Bochum, Germany.
Marlena RohmDepartment of Neurology, BG-University Hospital Bergmannsheil gGmbH, Ruhr University Bochum, Bochum, Germany.
Michaela ZaikDepartment of Neurology, BG-University Hospital Bergmannsheil gGmbH, Ruhr University Bochum, Bochum, Germany.
Nassam DayaDepartment of Neurology, BG-University Hospital Bergmannsheil gGmbH, Ruhr University Bochum, Bochum, Germany.
Anne-Katrin GüttschesDepartment of Neurology, BG-University Hospital Bergmannsheil gGmbH, Ruhr University Bochum, Bochum, Germany.
Carsten TheissMedical Imaging Center (MIC), Electron Microscopy Medical Analysis - Core Facility (EMMACF), Faculty of Medicine, Ruhr University Bochum, 44780, Bochum, Germany.
Andreas RoosDepartment of Pediatric Neurology, Centre for Neuromuscular Disorders, Centre for Translational Neuro- and Behavioral Sciences, University Duisburg-Essen, Essen, Germany.
Tobias RuckDepartment of Neurology, BG-University Hospital Bergmannsheil gGmbH, Ruhr University Bochum, Bochum, Germany.
Frank JacobsenDepartment of Neurology, BG-University Hospital Bergmannsheil gGmbH, Ruhr University Bochum, Bochum, Germany.
Lara SchlaffkeDepartment of Neurology, BG-University Hospital Bergmannsheil gGmbH, Ruhr University Bochum, Bochum, Germany.
Matthias VorgerdDepartment of Neurology, BG-University Hospital Bergmannsheil gGmbH, Ruhr University Bochum, Bochum, Germany. matthias.vorgerd@rub.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Establishing well-described mouse models of hereditary diseases is increasingly important for testing new therapeutic approaches, such as gene replacement therapy. In particular, a detailed description of muscle pathology, especially at early timepoints of the disease, is crucial for determining the optimal timepoint for drug delivery and evaluation of therapeutic success. In this study, we aimed to characterize and quantify the muscle pathology and myofibre morphology of different muscles in a new mouse model for calpainopathy as an example of the heterogenous group of limb girdle muscular dystrophies compared to wildtype controls during the disease. We analysed motor function and muscle tissue of wildtype and Capn3-transgenic mice per gender from 1.5 to 15 months of age. While transgenic mice did not develop restrictions in motor function, tested with grip strength measurement, beam walk and four limb wire hanging test, during this period, gastrocnemius, soleus and psoas muscles showed progressive histopathological and ultrastructural changes. Importantly, we also detected gender-specific differences in general muscle structure and in muscle pathology in the mouse model of calpainopathy. We developed a score to classify pathology of muscles in this mouse model using percentage of myocytes with centralized nuclei to increase objectivity and comparability when using this mouse model.

Indexed as

CalpainMuscle, SkeletalMuscular Dystrophies, Limb-GirdleAge FactorsAgingAnimalsDisease Models, AnimalFemaleMaleMiceMice, TransgenicMuscle ProteinsSex CharacteristicsSex FactorsCalpainCapn3 protein, mouseMuscle ProteinsCalpain 3CalpainopathyHistopathologyMouse model

Identifiers

PMID40940393
PMCPMC12432131

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.